Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo-Reference-Cited by-同舟云学术

Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo

Published:2017-08 Issue:4 Volume:170 Page:637-648.e10
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Horwitz Joshua A.,Bar-On Yotam,Lu Ching-Lan,Fera Daniela,Lockhart Ainsley A.K.,Lorenzi Julio C.C.,Nogueira Lilian,Golijanin Jovana,Scheid Johannes F.,Seaman Michael S.,Gazumyan Anna,Zolla-Pazner Susan,Nussenzweig Michel C.

Funder

NIH

Howard Hughes Medical Institute at Harvard Medical School

EMBO Long-Term Fellowship

Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai

Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery

NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

National Institute of Allergy and Infectious Diseases of the NIH

Robertson Foundation

Rockefeller University

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference80 articles.

1. A novel small reporter gene and HIV-1 fitness assay;Ali;J. Virol. Methods,2006

2. HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells;Alvarez;J. Virol.,2014

3. Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response;Andris;Proc. Natl. Acad. Sci. USA,1991

4. Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant;Andrus;J. Infect. Dis.,1998

5. Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity;Arias;Proc. Natl. Acad. Sci. USA,2014

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity;Molecular Therapy;2024-07

3. ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement forin vivoefficacy against SARS-CoV-2;2024-06-21

4. Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems;Viruses;2024-06-09

5. Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection;Antibodies;2024-04-03